Research Progress and Clinical Value of Subendocardial Viability Ratio.
Haotai XieLan GaoFangfang FanYan-Jun GongYan ZhangPublished in: Journal of the American Heart Association (2024)
Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, with ischemic heart disease being a major contributor, either through coronary atherosclerotic plaque-related major vascular disease or coronary microvascular dysfunction. Obstruction of coronary blood flow impairs myocardial perfusion, which may lead to acute myocardial infarction in severe cases. The subendocardial viability ratio, also known as the Buckberg index, is a valuable tool for evaluation of myocardial perfusion because it reflects the balance between myocardial oxygen supply and oxygen demand. The subendocardial viability ratio can effectively evaluate the function of the coronary microcirculation and is associated with arterial stiffness. This ratio also has potential value in predicting adverse cardiovascular events and mortality in various populations. Moreover, the subendocardial viability ratio has demonstrated clinical significance in a range of diseases, including hypertension, aortic stenosis, peripheral arterial disease, chronic kidney disease, diabetes, and rheumatoid arthritis. This review summarizes the applications of the subendocardial viability ratio, its particular progress in the relevant research, and its clinical significance in cardiovascular diseases.
Keyphrases
- coronary artery disease
- cardiovascular events
- cardiovascular disease
- aortic stenosis
- coronary artery
- acute myocardial infarction
- left ventricular
- rheumatoid arthritis
- blood flow
- chronic kidney disease
- transcatheter aortic valve replacement
- ejection fraction
- blood pressure
- percutaneous coronary intervention
- aortic valve replacement
- aortic valve
- type diabetes
- transcatheter aortic valve implantation
- heart failure
- emergency department
- metabolic syndrome
- oxidative stress
- interstitial lung disease
- risk assessment
- cardiovascular risk factors
- climate change
- end stage renal disease
- systemic lupus erythematosus
- drug induced
- adverse drug